(Q46718851)

24 December 2017

title

Aspirin resistance is more common in lacunar strokes than embolic strokes and is related to stroke severity (English)

1 reference

24 December 2017

1 reference

1 reference

3

1 reference

24 December 2017

Christopher D Byrne

series ordinal

4

1 reference

24 December 2017

author name string

Nicola A Englyst

series ordinal

1

1 reference

24 December 2017

Gill Horsfield

series ordinal

2

1 reference

24 December 2017

publication date

5 March 2008

1 reference

24 December 2017

Journal of Cerebral Blood Flow & Metabolism

published in

1 reference

24 December 2017

volume

28

1 reference

24 December 2017

issue

6

1 reference

24 December 2017

page(s)

1196-1203

1 reference

24 December 2017

The antithrombotic profile of aspirin. Aspirin resistance, or simply failure?

cites work

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Pneumonia and urinary tract infection after acute ischaemic stroke: a tertiary analysis of the GAIN International trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Classification and natural history of clinically identifiable subtypes of cerebral infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Inflammation-mediated damage in progressing lacunar infarctions: a potential therapeutic target

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Aspirin-resistant thromboxane biosynthesis and the risk of myocardial infarction, stroke, or cardiovascular death in patients at high risk for cardiovascular events

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Effects of acetylsalicylic acid in stroke patients evidence of nonresponders in a subpopulation of treated patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Aspirin non-responder status in patients with recurrent cerebral ischemic attacks

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Profile and prevalence of aspirin resistance in patients with cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Aspirin improves endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Aspirin resistance in coronary artery disease is correlated to elevated markers for oxidative stress but not to the expression of cyclooxygenase (COX) 1/2, a novel COX-1 polymorphism or the PlA(1/2) polymorphism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Aspirin resistance: definitions, mechanisms, prevalence, and clinical significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Aspirin resistance and atherothrombotic disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

A -174G/C polymorphism of the interleukin-6 gene in patients with lacunar infarction

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Possible vascular-bed-specific role of interleukin-6 in young women with a history of myocardial infarction, lacunar cerebral infarction and deep vein thrombosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Narrative review: aspirin resistance and its clinical implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Aspirin protects low density lipoprotein from oxidative modification

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Increased basal platelet activity, plasma adiponectin levels, and diabetes mellitus are associated with poor platelet responsiveness to in vitro effect of aspirin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Overestimation of platelet aspirin resistance detection by thrombelastograph platelet mapping and validation by conventional aggregometry using arachidonic acid stimulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Interobserver agreement for the assessment of handicap in stroke patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

In vivo aspirin supplementation inhibits nitric oxide consumption by human platelets

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

Quantifying the effect of antiplatelet therapy: a comparison of the platelet function analyzer (PFA-100) and modified thromboelastography (mTEG) with light transmission platelet aggregometry

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Interleukin-6 and interleukin-1 receptor antagonist in acute stroke

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Measurements of acute cerebral infarction: a clinical examination scale

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Modulation of human endothelial cell permeability by combinations of the cytokines interleukin-1 alpha/beta, tumor necrosis factor-alpha and interferon-gamma

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

The –174G/C Polymorphism of the Interleukin 6 Gene Is a Hallmark of Lacunar Stroke and Not Other Ischemic Stroke Phenotypes

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Two-year follow-up of aspirin responder and aspirin non responder. A pilot-study including 180 post-stroke patients

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Zinc-induced copper deficiency: a report of three cases initially recognized on bone marrow examination

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Infection after acute stroke is associated with poor short-term outcome

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Platelet-activating factor stimulates interleukin-6 production by human endothelial cells and synergizes with tumor necrosis factor for enhanced production of granulocyte-macrophage colony stimulating factor

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Cytokine induction of platelet activation

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Experimental stroke induces massive, rapid activation of the peripheral immune system

1 reference

https://api.crossref.org/works/10.1038%2FJCBFM.2008.9

7 January 2021

Identifiers

DOI

10.1038/JCBFM.2008.9

1 reference

24 December 2017

1 reference

24 December 2017